4BIO Capital Portfolio Company Trogenix Unveils Revolutionary Platform to Transform Cancer Treatment Through Precision Viral Immunotherapy

4BIO Capital Becomes First UK Venture Fund Certified by Japan's AMED

4BIO Capital Strengthens Investment Team